StockData
Purple Biotech Ltd. logo

Purple Biotech Ltd. (PPBT) stock

PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 1/30
$1.71+0.00 (0.00%)

Close on Nov 18, 2026Market cap $1.59MP/E 0.0Yield –

Purple Biotech free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$5.66M. The highest annual figure on record is $1.55M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.66M–
FY2023Dec 31, 2023-$19.93M–
FY2022Dec 31, 2022-$16.76M–
FY2021Dec 31, 2021-$489.00K-131.6%
FY2020Dec 31, 2020$1.55M–
FY2019Dec 31, 2019-$1.98M–
FY2018Dec 31, 2018-$8.50M–
FY2017Dec 31, 2017-$8.64M–
FY2016Dec 31, 2016-$6.27M–
FY2015Dec 31, 2015-$3.32M–

More Purple Biotech figures

See a number that looks wrong?